Petros Pharmaceuticals Inc (NASDAQ: PTPI) is -87.92% lower on its value in year-to-date trading and has touched a low of $0.05 and a high of $0.94 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PTPI stock was last observed hovering at around $0.05 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.05, the stock is -34.70% and -62.76% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.74 million and changing 0.00% at the moment leaves the stock -83.88% off its SMA200. PTPI registered -94.63% loss for a year compared to 6-month loss of -85.03%. The firm has a 50-day simple moving average (SMA 50) of $0.12792 and a 200-day simple moving average (SMA200) of $0.295345.
The stock witnessed a -43.93% gain in the last 1 month and extending the period to 3 months gives it a -87.34%, and is -28.96% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 19.93% over the week and 22.09% over the month.
Petros Pharmaceuticals Inc (PTPI) has around 18 employees, a market worth around $2.55M and $5.11M in sales. Profit margin for the company is -524.20%. Distance from 52-week low is 4.62% and -94.94% from its 52-week high.
.
Petros Pharmaceuticals Inc (PTPI) Top Institutional Holders
12.0 institutions hold shares in Petros Pharmaceuticals Inc (PTPI), with institutional investors hold 5.17% of the company’s shares. The shares outstanding are 53.52M, and float is at 43.80M with Short Float at 3.38%. Institutions hold 4.86% of the Float.
Petros Pharmaceuticals Inc (PTPI) Insider Activity
#####
